MedPath
FDA Approval

ODEFSEY

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 10, 2018
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Emtricitabine(200 mg in 1 1)
Tenofovir(25 mg in 1 1)
Rilpivirine(25 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

A-S Medication Solutions

A-S Medication Solutions

830016429

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ODEFSEY

Product Details

NDC Product Code
50090-2340
Application Number
NDA208351
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
August 28, 2017
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
Code: G70B4ETF4SClass: ACTIBQuantity: 200 mg in 1 1
TenofovirActive
Code: FWF6Q91TZOClass: ACTIRQuantity: 25 mg in 1 1
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94EClass: IACT
Code: 212WAX8KDDClass: ACTIMQuantity: 25 mg in 1 1
POLYSORBATE 20Inactive
Code: 7T1F30V5YHClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
POLYVINYL ALCOHOL, UNSPECIFIEDInactive
Code: 532B59J990Class: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1AClass: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357Class: IACT
© Copyright 2025. All Rights Reserved by MedPath